Overview

Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the optimal dosage of the clinical trial which is evaluating the antihypertensive efficacy and the safety of OJP-2028 tablets in patients with the uncomplicated essential hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
Jeil Pharmaceutical Co., Ltd.
Treatments:
Antihypertensive Agents